Replies to post #11989 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>do Ovation effectively have first right of refusal on all ATryn applications in US now?<

Correct.

>If so it seems like a very cheap call option.<

With respect to HD and CABG/HR, the deal is more than a call option because there are contractual performance requirements for Ovation to retain its license. For DIC and acquired-deficiency indications other than CABG/HR, Ovation effectively has a call option.